Brett A. Grimaud Theravance Biopharma, Inc. (TBPH) insider trading activity

Brett A. Grimaud is SVP, GEN COUNSEL AND SECRETARY of Theravance Biopharma, Inc.. Currently has a direct ownership of 384,068 shares of TBPH, which is worth approximately $4.46 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 9,743 shares (Ordinary Shares) at a price of $9.45 per share, resulting in proceeds of $92,071. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 384K

2.47% 3M change

9.15% 12M change

Total Value Held $4.46 Million

Brett A. Grimaud Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Payment of exercise price or tax liability	$92,071 $9.45 p/Share	9,743 Reduced 2.47%	384,068 Ordinary Shares
Feb 28 2025	BUY Grant, award, or other acquisition	-	75,000 Added 16.0%	393,811 Ordinary Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$140,398 $9.66 p/Share	14,534 Reduced 4.36%	318,811 Ordinary Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$92,401 $9.97 p/Share	9,268 Reduced 2.71%	333,345 Ordinary Shares
Aug 20 2024	SELL Payment of exercise price or tax liability	$76,182 $8.22 p/Share	9,268 Reduced 2.63%	342,613 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$84,338 $9.1 p/Share	9,268 Reduced 2.57%	351,881 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	100,000 Added 21.71%	360,684 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$156,947 $8.92 p/Share	17,595 Reduced 6.32%	260,684 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$76,354 $10.37 p/Share	7,363 Reduced 2.58%	278,279 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$86,446 $9.7 p/Share	8,912 Reduced 3.03%	285,297 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$128,567 $11.21 p/Share	11,469 Reduced 3.75%	294,209 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	75,000 Added 19.74%	304,958 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$106,467 $10.44 p/Share	10,198 Reduced 4.25%	229,958 Ordinary Shares

BAG

Brett A. Grimaud

SVP, GEN COUNSEL AND SECRETARY

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account